Dr. Kim works as a clinician-educator at the Harborview (HMC) Liver Clinic and at the HMC Madison Clinic. She is the Director of the Madison Hepatitis Coinfection Clinic. She serves as Director of the UW/Fred Hutch Center for AIDS Research Translational Research Subcore and is the Associate Editor for Hepatitis C Online, a CDC-sponsored web-based curriculum.
Dr. Kim is the lead investigator for the Liver Disease section of the UW Center for AIDS Research Clinical Cohort & Comorbidity Core. Her research has included work on chronic viral hepatitis, as well as alcohol-related and liver-related outcomes in people living with HIV. Dr. Kim also heads the AID Research Collaboratory (ARC), a Division initiative to foster patient-centered clinical investigation and catalyze quality improvement activities and health services research that leverage the electronic medical record.
Viral hepatitis and liver disease in people living with HIV
- Health equity
- Quality Improvement science
- Viral hepatitis
- General infectious disease
education & training
MD, University of California San Francisco, School of Medicine, San Francisco CA (1999)
MS, Epidemiology, University of Washington, School of Public Health & Community Medicine, Seattle WA (2005)
Chief Medical Resident, VA Puget Sound Health Care System, Seattle WA (1999-2002)
Fellowship in Infectious Diseases, University of Washington, Seattle WA (2003-2006)
Phi Beta Kappa, Harvard University (1993)
DSW Fellow Research Award, Infectious Disease Society of Washington (2005)
Infectious Disease Society of America Fellow Travel Award (2006)
UW PRAISE (Patient Reported Assessment in Satisfaction and Excellence) Award (2015)
Infectious Disease Society of America Leadership Institute (2019)
Kim HN, Newcomb CW, Carbonari DM, Roy JA Torgersen J, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Sun J, Hull M, Gill MJ, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Lo Re V 3rd. Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America. Hepatology. 2021 Mar 29;. doi: 10.1002/hep.31839.
Kennedy K, Graham SM, Arora N, Shuhart MC, Kim HN. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis. PLoS One. 2018 Sep 25; 13(9):e0204031.
• PubMed PMID: 30252863
Kim HN, Nance R, Van Rompaey S, Delaney JC, Crane HM, et al. Poorly controlled HIV infection: an independent risk factor for liver fibrosis. J Acquir Immune Defic Syndr. 2016 Aug 1; 72(4):437-43.
• PubMed Abstract
Kim HN, Rodriguez CV, Van Rompaey S, et. al. Factors associated with delayed hepatitis B viral suppression on Tenofovir among HBV-HIV coinfected patients in the CNICS cohort. J Acquir Immune Defic Syndr. 2014; 66:96-101.
• PubMed Abstract
Kim HN, Scott J, Cent A, Cook L, Ashley-Morrow R, Richardson B, et al. HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya. J Viral Hep. 2011; 18(10):e447-52.